INT244641

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.07
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 2.55
Pain Relevance 0.06

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

mitochondrion (MTOR) Golgi apparatus (MTOR) endoplasmic reticulum (MTOR)
embryo development (PDGFA) cytoplasm (MTOR) cell-cell signaling (PDGFA)
Anatomy Link Frequency
platelet 2
PDGFA (Homo sapiens)
MTOR (Homo sapiens)
Pain Link Frequency Relevance Heat
cytokine 14 60.88 Quite High
Pain 4 5.00 Very Low Very Low Very Low
methotrexate 2 5.00 Very Low Very Low Very Low
cva 2 5.00 Very Low Very Low Very Low
antagonist 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Renal Cancer 116 98.24 Very High Very High Very High
Cancer 60 88.12 High High
Syndrome 2 86.32 High High
Disease 46 85.20 High High
Toxicity 16 82.00 Quite High
Spontaneous Remission 2 53.12 Quite High
Genitourinary Tract Cancer 2 50.00 Quite Low
Fibromyalgia 4 48.96 Quite Low
Metastasis 8 41.24 Quite Low
Reprotox - General 1 76 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Growth factors such as vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and platelet-derived growth factor (PDGF) and their downstream signalling pathways including phosphatidylinositol 3-kinase (P13K) and mammalian target of rapamycin (mTOR) became new targets in the crusade against RCC.
platelet-derived growth factor Regulation (target) of mTOR in platelet associated with renal cancer
1) Confidence 0.07 Published 2008 Journal J Hematol Oncol Section Body Doc Link PMC2527326 Disease Relevance 1.31 Pain Relevance 0.03
Growth factors such as vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and platelet-derived growth factor (PDGF) and their downstream signalling pathways including phosphatidylinositol 3-kinase (P13K) and mammalian target of rapamycin (mTOR) became new targets in the crusade against RCC.
PDGF Regulation (target) of mTOR in platelet associated with renal cancer
2) Confidence 0.07 Published 2008 Journal J Hematol Oncol Section Body Doc Link PMC2527326 Disease Relevance 1.24 Pain Relevance 0.03

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox